v v wnt 3a conditioned medium Search Results


v e 3  (ATCC)
97
ATCC v e 3
V E 3, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/v e 3/product/ATCC
Average 97 stars, based on 1 article reviews
v e 3 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

90
Thermo Fisher gene exp sema3a hs00173810 m1
Gene Exp Sema3a Hs00173810 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp sema3a hs00173810 m1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
gene exp sema3a hs00173810 m1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher bodipy v-1002
Bodipy V 1002, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bodipy v-1002/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
bodipy v-1002 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher bodipy fl c5-lactosylceramide complexed to bsa
KEY RESOURCES TABLE
Bodipy Fl C5 Lactosylceramide Complexed To Bsa, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bodipy fl c5-lactosylceramide complexed to bsa/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
bodipy fl c5-lactosylceramide complexed to bsa - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher bodipy 505/515 staining
KEY RESOURCES TABLE
Bodipy 505/515 Staining, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bodipy 505/515 staining/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
bodipy 505/515 staining - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Molsoft LLC icm pro software v 3.9-3a/macosx
KEY RESOURCES TABLE
Icm Pro Software V 3.9 3a/Macosx, supplied by Molsoft LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/icm pro software v 3.9-3a/macosx/product/Molsoft LLC
Average 90 stars, based on 1 article reviews
icm pro software v 3.9-3a/macosx - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher drierite indicating desiccant
KEY RESOURCES TABLE
Drierite Indicating Desiccant, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/drierite indicating desiccant/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
drierite indicating desiccant - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

97
ATCC wnt3a conditioned medium
KEY RESOURCES TABLE
Wnt3a Conditioned Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wnt3a conditioned medium/product/ATCC
Average 97 stars, based on 1 article reviews
wnt3a conditioned medium - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

90
Thermo Fisher gene exp sema3a mm00436469 m1
KEY RESOURCES TABLE
Gene Exp Sema3a Mm00436469 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp sema3a mm00436469 m1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
gene exp sema3a mm00436469 m1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Cambridge Isotope Laboratories bvos
a CRISPR-Cas9 genome editing was used to generate PFKFB3 knockout iPS cells. Immunofluorescence confocal imaging of unedited control (CTR) and PFKFB3 knockout (P206, P208) BVO sections showing pericyte coverage (PDGFRβ, magenta) of CD31 + ECs (green). b Percentage of pericyte coverage CTR n = 6 <t>BVOs,</t> P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations. One-two sections per BVO were assessed. c Quantification of vessel density and ( d ) length in CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations in four different areas per x10 images. One-two sections per BVO were assessed. Values are presented as mean ± SD using two-way ANOVA followed by Tukey’s multiple comparisons tests. ( b : CTR vs. P206 **** p = 0.000000000522; CTR vs. P208 **** p = 0.000000128; c : * p = 0.0374; CTR vs P206 **** p = 0.000027; CTR vs P208 **** p = 0.000000022; d : CTR vs P206 **** p = 0.000088; CTR vs P208 **** p = 0.000005). ns not significant. Bar scales 200 and 50 μm. Effect of PFKFB3 knockout on 13 C label incorporation into metabolites related to ( e ) glycolysis, ( f ) the TCA cycle and ( g ) glycolytic branch pathways after 3 h <t>of</t> <t>incubation</t> with 13 C 6 -glucose. Data represents mean ± SEM, n = 4 independent experiments, statistical significance was assessed by a two-way ANOVA with Holm-Sidak post-hoc test. ( e : LAC ** p = 0.00618; PEP ** p = 0.00531; DHAP * p = 0.02990; G3P **** p = 0.000000798; FBP * p = 0.02749; F6P * p = 0.04479; G6P* p = 0.00473). G6P glucose 6-phosphate, F6P fructose 6-phosphate, FBP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 1,3-BPG 1,3-bisphosphoglycerate, 2-PG 2-phosphoglycerate, PEP phosphoenolpyruvate, LAC lactate, UDP uridine diphosphate, GlcNAc N -acetylglucosamine, Ru5P ribulose 5-phosphate, R5P ribose 5-phosphate, S7P sedoheptulose-7-phosphate, m + x mass isotopologues x. Source data are provided as a Source Data file.
Bvos, supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bvos/product/Cambridge Isotope Laboratories
Average 93 stars, based on 1 article reviews
bvos - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

95
R&D Systems mouse recombinant wnt3a
a CRISPR-Cas9 genome editing was used to generate PFKFB3 knockout iPS cells. Immunofluorescence confocal imaging of unedited control (CTR) and PFKFB3 knockout (P206, P208) BVO sections showing pericyte coverage (PDGFRβ, magenta) of CD31 + ECs (green). b Percentage of pericyte coverage CTR n = 6 <t>BVOs,</t> P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations. One-two sections per BVO were assessed. c Quantification of vessel density and ( d ) length in CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations in four different areas per x10 images. One-two sections per BVO were assessed. Values are presented as mean ± SD using two-way ANOVA followed by Tukey’s multiple comparisons tests. ( b : CTR vs. P206 **** p = 0.000000000522; CTR vs. P208 **** p = 0.000000128; c : * p = 0.0374; CTR vs P206 **** p = 0.000027; CTR vs P208 **** p = 0.000000022; d : CTR vs P206 **** p = 0.000088; CTR vs P208 **** p = 0.000005). ns not significant. Bar scales 200 and 50 μm. Effect of PFKFB3 knockout on 13 C label incorporation into metabolites related to ( e ) glycolysis, ( f ) the TCA cycle and ( g ) glycolytic branch pathways after 3 h <t>of</t> <t>incubation</t> with 13 C 6 -glucose. Data represents mean ± SEM, n = 4 independent experiments, statistical significance was assessed by a two-way ANOVA with Holm-Sidak post-hoc test. ( e : LAC ** p = 0.00618; PEP ** p = 0.00531; DHAP * p = 0.02990; G3P **** p = 0.000000798; FBP * p = 0.02749; F6P * p = 0.04479; G6P* p = 0.00473). G6P glucose 6-phosphate, F6P fructose 6-phosphate, FBP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 1,3-BPG 1,3-bisphosphoglycerate, 2-PG 2-phosphoglycerate, PEP phosphoenolpyruvate, LAC lactate, UDP uridine diphosphate, GlcNAc N -acetylglucosamine, Ru5P ribulose 5-phosphate, R5P ribose 5-phosphate, S7P sedoheptulose-7-phosphate, m + x mass isotopologues x. Source data are provided as a Source Data file.
Mouse Recombinant Wnt3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse recombinant wnt3a/product/R&D Systems
Average 95 stars, based on 1 article reviews
mouse recombinant wnt3a - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

99
Thermo Fisher bodipy fl ceramide bsa
Sphingolipids transport to the inclusions is interfered by Akt inhibition. (A) Infected cells (MOI 2) were incubated with DMSO or increasing concentrations of iAkt (2, 5, and 10 μM) from 2 to 24 h pi. Before fixation, cells were incubated for 30 min with <t>Ceramide-BODIPY</t> at 4°C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37°C. Finally, bacteria were detected with anti-MOMP coupled to FITC. (B) Intensity profiles obtained by scanning red (SM) and green ( Ct ) fluorescence along a line that crosses inclusions. (C) In experiments conducted as described in (A) , Golgi apparatus was detected with mouse anti-GM130 antibody followed by anti-mouse Cy5-coupled secondary antibody. Bacteria were detected with anti-MOMP coupled to FITC. DAPI stained nuclei (N) and bacterial DNA. Concentration and localization of sphingolipids are depicted in the bottom panels. Fire scale represents the fluorescence intensity associated to sphingolipids. Golgi apparatus is delimited with a white line. (D) Fluorescence intensity corresponding to sphingolipids at the Golgi apparatus was quantified using ImageJ. Data are representative of three independent experiments ( ∗∗∗ p < 0.001, ∗∗ p < 0.01).
Bodipy Fl Ceramide Bsa, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bodipy fl ceramide bsa/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
bodipy fl ceramide bsa - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Immunity

Article Title: The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses

doi: 10.1016/j.immuni.2020.11.003

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: BODIPY FL C5-Lactosylceramide complexed to BSA , Thermo Fisher Scientific , Cat# B34402.

Techniques: Recombinant, Derivative Assay, Enzyme-linked Immunosorbent Assay, Sequencing, CRISPR, Biomarker Discovery, Plasmid Preparation, Retroviral, Expressing, Software, Single-cell Analysis, Pore Size, Saline

a CRISPR-Cas9 genome editing was used to generate PFKFB3 knockout iPS cells. Immunofluorescence confocal imaging of unedited control (CTR) and PFKFB3 knockout (P206, P208) BVO sections showing pericyte coverage (PDGFRβ, magenta) of CD31 + ECs (green). b Percentage of pericyte coverage CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations. One-two sections per BVO were assessed. c Quantification of vessel density and ( d ) length in CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations in four different areas per x10 images. One-two sections per BVO were assessed. Values are presented as mean ± SD using two-way ANOVA followed by Tukey’s multiple comparisons tests. ( b : CTR vs. P206 **** p = 0.000000000522; CTR vs. P208 **** p = 0.000000128; c : * p = 0.0374; CTR vs P206 **** p = 0.000027; CTR vs P208 **** p = 0.000000022; d : CTR vs P206 **** p = 0.000088; CTR vs P208 **** p = 0.000005). ns not significant. Bar scales 200 and 50 μm. Effect of PFKFB3 knockout on 13 C label incorporation into metabolites related to ( e ) glycolysis, ( f ) the TCA cycle and ( g ) glycolytic branch pathways after 3 h of incubation with 13 C 6 -glucose. Data represents mean ± SEM, n = 4 independent experiments, statistical significance was assessed by a two-way ANOVA with Holm-Sidak post-hoc test. ( e : LAC ** p = 0.00618; PEP ** p = 0.00531; DHAP * p = 0.02990; G3P **** p = 0.000000798; FBP * p = 0.02749; F6P * p = 0.04479; G6P* p = 0.00473). G6P glucose 6-phosphate, F6P fructose 6-phosphate, FBP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 1,3-BPG 1,3-bisphosphoglycerate, 2-PG 2-phosphoglycerate, PEP phosphoenolpyruvate, LAC lactate, UDP uridine diphosphate, GlcNAc N -acetylglucosamine, Ru5P ribulose 5-phosphate, R5P ribose 5-phosphate, S7P sedoheptulose-7-phosphate, m + x mass isotopologues x. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity

doi: 10.1038/s41467-023-41326-2

Figure Lengend Snippet: a CRISPR-Cas9 genome editing was used to generate PFKFB3 knockout iPS cells. Immunofluorescence confocal imaging of unedited control (CTR) and PFKFB3 knockout (P206, P208) BVO sections showing pericyte coverage (PDGFRβ, magenta) of CD31 + ECs (green). b Percentage of pericyte coverage CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations. One-two sections per BVO were assessed. c Quantification of vessel density and ( d ) length in CTR n = 6 BVOs, P206 n = 7 BVOs, P208 n = 7 BVOs, from three separate preparations in four different areas per x10 images. One-two sections per BVO were assessed. Values are presented as mean ± SD using two-way ANOVA followed by Tukey’s multiple comparisons tests. ( b : CTR vs. P206 **** p = 0.000000000522; CTR vs. P208 **** p = 0.000000128; c : * p = 0.0374; CTR vs P206 **** p = 0.000027; CTR vs P208 **** p = 0.000000022; d : CTR vs P206 **** p = 0.000088; CTR vs P208 **** p = 0.000005). ns not significant. Bar scales 200 and 50 μm. Effect of PFKFB3 knockout on 13 C label incorporation into metabolites related to ( e ) glycolysis, ( f ) the TCA cycle and ( g ) glycolytic branch pathways after 3 h of incubation with 13 C 6 -glucose. Data represents mean ± SEM, n = 4 independent experiments, statistical significance was assessed by a two-way ANOVA with Holm-Sidak post-hoc test. ( e : LAC ** p = 0.00618; PEP ** p = 0.00531; DHAP * p = 0.02990; G3P **** p = 0.000000798; FBP * p = 0.02749; F6P * p = 0.04479; G6P* p = 0.00473). G6P glucose 6-phosphate, F6P fructose 6-phosphate, FBP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 1,3-BPG 1,3-bisphosphoglycerate, 2-PG 2-phosphoglycerate, PEP phosphoenolpyruvate, LAC lactate, UDP uridine diphosphate, GlcNAc N -acetylglucosamine, Ru5P ribulose 5-phosphate, R5P ribose 5-phosphate, S7P sedoheptulose-7-phosphate, m + x mass isotopologues x. Source data are provided as a Source Data file.

Article Snippet: For BVOs, a 3 h incubation with 5 mM U- 13 C 6 -glucose (Cambridge Isotope Laboratories) in DMEM without glucose and pyruvate (Thermo Fisher Scientific) supplemented with 1% penicillin-streptomycin and 1% l -glutamine was performed.

Techniques: CRISPR, Knock-Out, Immunofluorescence, Imaging, Control, Incubation

Sphingolipids transport to the inclusions is interfered by Akt inhibition. (A) Infected cells (MOI 2) were incubated with DMSO or increasing concentrations of iAkt (2, 5, and 10 μM) from 2 to 24 h pi. Before fixation, cells were incubated for 30 min with Ceramide-BODIPY at 4°C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37°C. Finally, bacteria were detected with anti-MOMP coupled to FITC. (B) Intensity profiles obtained by scanning red (SM) and green ( Ct ) fluorescence along a line that crosses inclusions. (C) In experiments conducted as described in (A) , Golgi apparatus was detected with mouse anti-GM130 antibody followed by anti-mouse Cy5-coupled secondary antibody. Bacteria were detected with anti-MOMP coupled to FITC. DAPI stained nuclei (N) and bacterial DNA. Concentration and localization of sphingolipids are depicted in the bottom panels. Fire scale represents the fluorescence intensity associated to sphingolipids. Golgi apparatus is delimited with a white line. (D) Fluorescence intensity corresponding to sphingolipids at the Golgi apparatus was quantified using ImageJ. Data are representative of three independent experiments ( ∗∗∗ p < 0.001, ∗∗ p < 0.01).

Journal: Frontiers in Microbiology

Article Title: Akt/AS160 Signaling Pathway Inhibition Impairs Infection by Decreasing Rab14-Controlled Sphingolipids Delivery to Chlamydial Inclusions

doi: 10.3389/fmicb.2019.00666

Figure Lengend Snippet: Sphingolipids transport to the inclusions is interfered by Akt inhibition. (A) Infected cells (MOI 2) were incubated with DMSO or increasing concentrations of iAkt (2, 5, and 10 μM) from 2 to 24 h pi. Before fixation, cells were incubated for 30 min with Ceramide-BODIPY at 4°C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37°C. Finally, bacteria were detected with anti-MOMP coupled to FITC. (B) Intensity profiles obtained by scanning red (SM) and green ( Ct ) fluorescence along a line that crosses inclusions. (C) In experiments conducted as described in (A) , Golgi apparatus was detected with mouse anti-GM130 antibody followed by anti-mouse Cy5-coupled secondary antibody. Bacteria were detected with anti-MOMP coupled to FITC. DAPI stained nuclei (N) and bacterial DNA. Concentration and localization of sphingolipids are depicted in the bottom panels. Fire scale represents the fluorescence intensity associated to sphingolipids. Golgi apparatus is delimited with a white line. (D) Fluorescence intensity corresponding to sphingolipids at the Golgi apparatus was quantified using ImageJ. Data are representative of three independent experiments ( ∗∗∗ p < 0.001, ∗∗ p < 0.01).

Article Snippet: Infected cells grown on 12-mm-diameter glass coverslips in 24-well plates were treated with iAkt for the indicated periods of time; and before its fixation, cells were incubated with 5 μM BODIPY TR ceramide-BSA complex in DMEM or BODIPY FL ceramide-BSA (Molecular Probes, United States) for 30 min at 4°C, then washed 3 times with PBS, and finally, maintained in DMEM without FBS for 30 min at 37°C.

Techniques: Inhibition, Infection, Incubation, Bacteria, Fluorescence, Staining, Concentration Assay

Disruption of the Akt/AS160 pathway causes retention of lipids at the Golgi apparatus. (A) Equal amounts of lipids extracted from infected cells incubated with DMSO, 2 μM or 10 μM iAkt were resolved by thin layer chromatography (TLC). A representative TLC from two independent experiments is shown. (B) HeLa cells were transfected with either siRNA-Luc or siRNA-AS160 and, 48 h later, infected with GFP-expressing C. trachomatis (MOI of 1). AS160-silenced and control cells were incubated with DMSO or increasing concentrations of iAkt (2 or 10 μM). After 24 h of infection and before fixation, cells were incubated for 30 min with BODIPY TR ceramide at 4°C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37°C. Golgi apparatus was immunodetected in fixed cells with mouse anti-GM130 monoclonal antibody followed by Cy5 coupled anti-mouse secondary antibody. Bars show the average fluorescence intensity of lipids at the Golgi apparatus. ImageJ was used for this analysis. (C) Representative images of two independent experiments performed as indicated in (B) . In the upper panels, subcellular distribution of sphigolipids appears in red. GFP expressing bacteria are shown in green. Golgi was stained with mouse anti-GM130 followed by anti-mouse Cy5-coupled secondary antibody (white). In the lower panel, fire scale represents the fluorescence intensity associated to sphingolipids. White lines demarcate Golgi structures. Nuclei were stained with DAPI. Asterisks indicate inclusions.

Journal: Frontiers in Microbiology

Article Title: Akt/AS160 Signaling Pathway Inhibition Impairs Infection by Decreasing Rab14-Controlled Sphingolipids Delivery to Chlamydial Inclusions

doi: 10.3389/fmicb.2019.00666

Figure Lengend Snippet: Disruption of the Akt/AS160 pathway causes retention of lipids at the Golgi apparatus. (A) Equal amounts of lipids extracted from infected cells incubated with DMSO, 2 μM or 10 μM iAkt were resolved by thin layer chromatography (TLC). A representative TLC from two independent experiments is shown. (B) HeLa cells were transfected with either siRNA-Luc or siRNA-AS160 and, 48 h later, infected with GFP-expressing C. trachomatis (MOI of 1). AS160-silenced and control cells were incubated with DMSO or increasing concentrations of iAkt (2 or 10 μM). After 24 h of infection and before fixation, cells were incubated for 30 min with BODIPY TR ceramide at 4°C in serum-free DMEM. Then, cells were washed with PBS and incubated with DMEM supplemented with FBS for 30 min at 37°C. Golgi apparatus was immunodetected in fixed cells with mouse anti-GM130 monoclonal antibody followed by Cy5 coupled anti-mouse secondary antibody. Bars show the average fluorescence intensity of lipids at the Golgi apparatus. ImageJ was used for this analysis. (C) Representative images of two independent experiments performed as indicated in (B) . In the upper panels, subcellular distribution of sphigolipids appears in red. GFP expressing bacteria are shown in green. Golgi was stained with mouse anti-GM130 followed by anti-mouse Cy5-coupled secondary antibody (white). In the lower panel, fire scale represents the fluorescence intensity associated to sphingolipids. White lines demarcate Golgi structures. Nuclei were stained with DAPI. Asterisks indicate inclusions.

Article Snippet: Infected cells grown on 12-mm-diameter glass coverslips in 24-well plates were treated with iAkt for the indicated periods of time; and before its fixation, cells were incubated with 5 μM BODIPY TR ceramide-BSA complex in DMEM or BODIPY FL ceramide-BSA (Molecular Probes, United States) for 30 min at 4°C, then washed 3 times with PBS, and finally, maintained in DMEM without FBS for 30 min at 37°C.

Techniques: Disruption, Infection, Incubation, Thin Layer Chromatography, Transfection, Expressing, Control, Fluorescence, Bacteria, Staining